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ALZHEIMER’S DISEASE: THIRTY YEARS OF PROGRESS
Stanley I. Rapoport, M.D.
Alzheimer’s disease is the major cause of dementia in the United States, with spending in the range of $100
billion annually. It affects 5 to 7 percent of people over 65 years of age and 20 to 40 percent over 80, and is
estimated to be the fourth to fifth most common cause of death in the United States. 
Concerted research efforts in the clinical and basic neurosciences in the last 30 years have resulted in marked
advances in our understanding of the clinical course and mechanisms of Alzheimer’s disease as well as new
therapeutic directions. This review provides a short history of the progress that has been made in Alzheimer’s
disease research during this time, and identifies some of the seminal discoveries and insights that contributed
to this progress. 
A Brief History
In 1907, Alois Alzheimer reported that the brain of a 55-year-old deceased woman who had a history of pro-
gressive memory loss accompanied by morbid jealousy contained high densities of plaques and silver-staining
accumulations of twisted protein fragments. These fragments were located inside the brain’s nerve cells. He
referred to them as “neurofibrillary tangles.” The dementia associated with this neuropathological picture
became known as “Alzheimer’s disease.” 
Following Alzheimer’s report, neuropathologists in psychiatric and other hospital settings accumulated large
sets of clinical and postmortem data from Alzheimer’s disease patients. It was not until the 1970s, when the
full impact of Alzheimer’s disease was recognized, that its symptoms, mechanisms, risk and genetic factors,
and treatment began to be seriously addressed. These data became important in distinguishing Alzheimer’s
disease from brain changes that are found in other dementias, such as vascular dementia.
In the last 30 years, progress on Alzheimer’s disease consisted of concurrent advances in different areas of the
clinical and basic neurosciences, including clinical description, neuropathology, molecular biology, cognitive
assessment, brain imaging, epidemiology, genetics, and treatment. This progress was supported in part by
increased funding from the National Institutes of Health (NIH), whose annual research budget grew from only
$3.9 million in 1976 to approximately $650 million today.  







CAREGIVING FOR ALZHEIMER’S DISEASE:
CHALLENGES AND OPPORTUNITIES
Larry D. Wright, M.D.
Among the most disturbing and inspiring professional experiences for most practicing geriatricians are the
times spent working with patients and families facing the struggles of living with Alzheimer’s disease. This
has certainly been true for me.
In 26 years of community-based geriatric medicine practice, I have had the privilege of working with more
Alzheimer’s disease (AD) patients and families than I can easily recall. But my collective impression has been
indelible and very rewarding, even though the immediate impact of so many of these cases has been a strong
mixture of heartbreak and inspiration. And certainly I can testify that I am a better physician for having had
these experiences and, I believe, a better person. Like the families and caregivers I’ve known, I often have felt
very inadequate and unprepared for the problems AD presents. Such is the nature of this devastating disease.
Two case vignettes (here and at the conclusion of this essay) offer contrasting experiences of Alzheimer’s
caregiving and illustrate some of the more tragic and successful potential scenarios for patients and families
afflicted with AD or other dementias.
Mary and Ed Brown had just celebrated their fifty-third wedding anniversary when his longtime family doctor
told Mary that Ed’s recent forgetfulness and problems balancing the checkbook probably meant he had
Alzheimer’s disease. No further tests or treatment was recommended since she was told the disorder was
incurable and the only medicine was not really effective but very expensive. She was told to let him live as
normal a life as possible for as long as possible and that she would know when to put him in a nursing home.
The ensuing two years were marked by a very gradual decline in cognitive ability mostly obvious only to Mary
and a few close friends. A son and daughter both resided at a great distance and, though very devoted to their
parents, expressed doubts about the accuracy of the diagnosis, having seen only minor examples of the func-
tional and behavioral problems their mother described.
A few embarrassing episodes with friends resulted in fewer opportunities for social activity away from home.
Ed lost interest in golf and preferred to stay at home with Mary most of the time. 
After two minor car accidents, the family tried to encourage Ed to quit driving, but he refused to do so,
adamantly claiming the accidents were not his fault and that he was an excellent driver. He also refused to
consider the couple’s moving closer to the children. And though Mary realized soon thereafter that he should
not be left alone, Ed objected to her leaving him with someone else, even close friends, however briefly.
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